Evidence map›Paper›PMID 35243639›Full record

ArticleHealth services research2022

Did prescribing laws disproportionately affect opioid dispensing to Black patients?

Tarlise N Townsend, Amy S B Bohnert, Pooja Lagisetty, Rebecca L Haffajee

Abstract read
In one paragraph

Article in Health services research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Observational
  12. Racial and Ethnic Disparities in Opioid Access and Urine Drug Screening Among Older Patients With Poor-Prognosis Cancer Near the End of Life.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023
    Article
  13. Observational
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Tarlise N TownsendDepartment of Health Management and Policy, University of Michigan, Ann Arbor, Michigan, USA.ORCID 0000-0001-7459-9798
Amy S B BohnertDepartment of Anesthesiology, Psychiatry, and Epidemiology, University of Michigan, Ann Arbor, Michigan, USA.
Pooja LagisettyDepartment of Veterans Affairs, Center for Clinical Management Research, Ann Arbor, Michigan, USA.
Rebecca L HaffajeeU.S. Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, Washington, District of Columbia, USA.

Funding

BEHAVIORAL SCI TRAINING IN DRUG ABUSE RESEARCHT32DA007233 · NIDA · PUBLIC HEALTH SOLUTIONS · PI GOLDSAMT, LLOYD A · 1985 to 2023
$20.2M
A Tailored Behavioral Intervention To Increase Engagement in Opioid Tapering in Primary Care SettingsK23DA047475 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LAGISETTY, POOJA · 2019 to 2023
$970k
NIDA NIH HHS K23 DA047475NIDA NIH HHS T32 DA007233
6 · The paper itself

Abstract

objectiveTo evaluate whether pain management clinic laws and prescription drug monitoring program (PDMP) prescriber check mandates, two state opioid policies with relatively rapid adoption across states, reduced opioid dispensing more or less in Black versus White patients. DATA SOURCES: Pharmacy claims data, US sample of commercially insured adults, 2007-2018. STUDY

designStratifying by race, we used generalized estimating equations with an event-study specification to estimate time-varying effects of each policy on opioid dispensing, comparing to the four pre-policy quarters and states without the policy. Outcomes included high-dosage opioids, overlapping opioid prescriptions, concurrent opioid/benzodiazepines, opioids from >3 prescribers, opioids from >3 pharmacies. DATA EXTRACTION

methodsWe identified all prescription opioid dispensing to Black and White adults aged 18-64 without a palliative care or cancer diagnosis code. PRINCIPAL

findingsExactly 7,096,592 White and 1,167,310 Black individuals met inclusion criteria. Pain management clinic laws were associated with reductions in two outcomes; their association with high-dosage receipt was larger among White patients. In contrast, reductions due to PDMP mandates appeared limited to, or larger in, Black patients compared with White patients in four of five outcomes. For example, PDMP mandates reduced high-dosage receipt in Black patients by 0.7 percentage points (95% CI: 0.36-1.08 ppt.) over 4 years: an 8.4% decrease from baseline; there was no apparent effect in White patients. Similarly, while there was limited evidence that mandates reduced overlapping opioid receipt in White patients, they appeared to reduce overlapping opioid receipt in Black patients by 1.3 ppt. (95% CI: -1.66--1.01 ppt.) across post-policy years-a 14.4% decrease from baseline.

conclusionsPDMP prescriber check mandates but not pain management clinic laws appeared to reduce opioid dispensing more in Black patients than White patients. Future research should discern the mechanisms underlying these disparities and their consequences for pain management.

Indexed as

Analgesics, OpioidPrescription Drug Monitoring ProgramsAdultBenzodiazepinesHumansPain ManagementPolicyPractice Patterns, Physicians'Analgesics, OpioidBenzodiazepinesopioidspolicyprescriptionsracial discriminationracial disparitiesracial inequity

Identifiers

PMID35243639
PMCPMC9108058

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.